Search PubMed⌕ Search

Biomedical subjects

M Fatome

Publications and source records attributed to M Fatome.

33 records · Page 2Linked to original sources

The binding of the radioprotective agent cysteamine with the phospholipidic membrane headgroup-interface region.

The interaction of the aminothiol radioprotector cysteamine (beta-mercaptoethylamine) (CYST) with dipalmitoylphosphatidylcholine (DPPC) artificial membranes has been studied by differential scanning calorimetry (DSC), turbidimetry and spin labeling. This hydrophilic molecule displays a biphasic, concentration-dependent binding to the phospholipidic head groups at neutral pH. In the CYST/DPPC molar ratio 1:160-1:2 (mole/mole) an increasing ordering effect is observed. At high concentrations (over 3:1 ratio), this ordering effect decreases. With the symmetric disulfide dimer cystamine, the biphasic effect is not shown and the membrane rigidity decrease is obtained only at concentration ratio higher than 1:1. The charge repartition of the cysteamine molecule has been shown to be disymmetric, +0.52 e on the NH3 group and +0.19 e on the SH extremity, [38] whereas the cystamine molecule is electrostatically symmetrical. These properties could be related to their membrane effects. With cysteamine, at a low concentration, an electrostatic bridging between the negatively charged phosphate groups of the polar heads induces the increase in membrane stability: the molecules behave like a divalent cation. At high concentrations a displacement of the slightly charged SH extremity by the amine disrupts the bridges and induces the decrease in rigidity: the drug behaves like a monovalent cation. Due to its symmetric charge and its double length, such an effect is not observed with cystamine. This study could bring further information about the interactions between cysteamine and polyelectrolytic structures (ADN for example) and about the radioprotective properties of this drug.

Binding Sites↗

Radioprotection of EMT6 tumor by a new class of radioprotectors based on a pseudo-peptide cysteamine combination.

Although WR-2721 preferentially protects normal tissues against irradiation, it seemed desirable to find other drugs presenting a lower toxicity and the same radioprotective properties. A new compound, I 102, was selected; it was characterized on one hand by a coupling between cysteamine and an amino-acid, and on the other hand by an acetyl-group, which protects the thiol function. The effects of WR-2721 and of I 102 were studied on EMT6 tumors grafted on BALB/c mice. Whatever the size of the tumor, the cell survival increased as a function of the time elapsed between the injection of I 102 and the end of the irradiation (TI). In contrast, the radioprotection afforded by WR-2721 was found to be independent of TI. The survival curves suggest that, like WR-2721, I 102 protects essentially oxygenated cells.

Amifostine↗

Oral administration of liposome-entrapped cysteamine and the distribution pattern in blood, liver and spleen.

Oral administration of liposome-entrapped cysteamine induces an increase in the concentration of exogenous sulphur compounds in blood (plasma), liver and spleen. Among those sulphur compounds, an important amount of plasma thiols can be related to a protection of cysteamine in the digestive tract. This can account for the radioprotective effect of a liposomal-cysteamine suspension in rodents, and clearly demonstrates the interest of such a preparation in radioprotection.

Administration, Oral↗

A study of the mechanism of cerebral hyperexcitability after irradiation.

Whole-body irradiation at a lethal dose induced an early and transient perturbation of 3H-Muscimol specific binding in the mouse cerebellum. The density of high affinity binding sites was decreased and was associated with an increased affinity. This effect can explain early radio-induced cerebral hyperexcitability. Previous injection of cysteamine, which protects against cerebral hyperexcitability, also offers a good protection against this effect.

Animals↗

[Radioprotective effect of acute non-specific inflammation in mice].

A full protection against a 8,5 Gy gamma irradiation is observed in Mice bearing a one day old granuloma induced by polyacrylamide microbeads, when these Mice are injected, 1 hr before irradiation, with the eluate obtained from a 1 day old granuloma. In these Mice, a striking increase of the uptake of 125IUdR in bone marrow is observed.

Animals↗

Relationship between metabolism and radioprotective activity of 2-phenylthiazolidine and its m-bromo derivative.

Molecular biotransformation of 2-phenylthiazolidine (1) and its m-bromo derivative (2) in the mouse is followed by autoradiographic studies and assessed by analysis of urinary metabolites. Cysteamine (4) is one of the metabolites of compounds 1 and 2. Radioprotective activity and efficacy over a period of time of 1, 2, and 4 correlate closely with distribution and metabolism.

Animals↗

[Radioprotective effect of cysteamine entrapped in liposomes orally administered to the mouse].

Cysteamine entrapped in liposomes was orally delivered to Mice and its radioprotective effect observed as a function of the time elapsed between its administration and 60Co gamma irradiation. A protection is manifest up to 3 hrs after administration. This result contrasts with the absence of protection afforded by cysteamine when orally given as an aqueous solution, and with the short lasting activity of its parenteral administration.

Administration, Oral↗

Radioprotection by thiazolidines at the cellular level.

Radioprotection by a number of thiazolidine derivatives was studied in vitro. Reproductive integrity of single cells was used as a parameter for survival after irradiation. Thiazolidine itself did not protect when dissolved in culture medium, but a good protective activity was found when it was dissolved in rat blood. Rat blood improved also the radioprotective activity of most other thiazolidine derivatives. The best protection was obtained with thiazolidines in which the carbon at the 2 position was substituted by germanium. No correlation was evident between the degree of protection and release of a free SH group by hydrolysis of the thiazolidine ring. The results support a previous suggestion by Terol, Fernandez, Robbe, Châpat, Granger and Sentenac-Rovmanov (1978) that the thiazolidines proper and not their hydrolysis products are responsible for radioprotection.

Cell Line↗